GoldenBiotech Antroquinonol Phase 2 NSCLC Clinical Study Presents Brilliant Results in ASCO Meeting.

2019/05/17

Golden Biotechnology Corp.’s Antroquinonol Phase 2 NSCLC Clinical Study Presents Advanced Results in ASCO Meeting Abstract....

Golden Biotechnology Corp. Starts Phase 2 Trial for Efficacy of Antroquinonol in AML after Russian MOH Approval

2019/01/16

Golden Biotechnology Corp.(TW4132) received the Russian MoH approval letter on January 16, 2019 for the implementation in Russia to perform Phase 2 clinical trial of acute myeloid leukemia (AML)...

 

Antroquinonol®

Antroquinonol® is the pure compound extracted from Antrodia camphorata. Antroquinonol® is patented by Golden Biotech and helps support the immune system.

We have finalized 10 new leading candidates for new drug development.

Antroquinonol® has applied for compound and use patents worldwide.